C4 Therapeutics (CCCC)
US Market

C4 Therapeutics (CCCC) Stock Price & Analysis


CCCC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.85 - $13.24
Previous Close$3.08
Average Volume (3M)532.78K
Market Cap
Enterprise Value$442.65M
Total Cash (Recent Filing)$49.48M
Total Debt (Recent Filing)$341.01M
Price to Earnings (P/E)-1.1
Aug 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.68
Shares Outstanding49,063,761
10 Day Avg. Volume598,238
30 Day Avg. Volume532,782
Standard Deviation0.22
Financial Highlights & Ratios
Price to Book (P/B)0.63
Price to Sales (P/S)40.20
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue18.18
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.89
Price Target Upside349.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was C4 Therapeutics’s price range in the past 12 months?
C4 Therapeutics lowest stock price was $2.85 and its highest was $13.23 in the past 12 months.
    What is C4 Therapeutics’s market cap?
    Currently, no data Available
    When is C4 Therapeutics’s upcoming earnings report date?
    C4 Therapeutics’s upcoming earnings report date is Aug 09, 2023 which is in 73 days.
      How were C4 Therapeutics’s earnings last quarter?
      C4 Therapeutics released its earnings results on May 04, 2023. The company reported -$0.71 earnings per share for the quarter, beating the consensus estimate of -$0.747 by $0.037.
        Is C4 Therapeutics overvalued?
        According to Wall Street analysts C4 Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does C4 Therapeutics pay dividends?
          C4 Therapeutics does not currently pay dividends.
          What is C4 Therapeutics’s EPS estimate?
          C4 Therapeutics’s EPS estimate is -$0.69.
            How many shares outstanding does C4 Therapeutics have?
            C4 Therapeutics has 49,063,763 shares outstanding.
              What happened to C4 Therapeutics’s price movement after its last earnings report?
              C4 Therapeutics reported an EPS of -$0.71 in its last earnings report, beating expectations of -$0.747. Following the earnings report the stock price went up 2.866%.
                Which hedge fund is a major shareholder of C4 Therapeutics?
                Among the largest hedge funds holding C4 Therapeutics’s share is Caxton Associates LP. It holds C4 Therapeutics’s shares valued at 122K.


                  C4 Therapeutics Stock Smart Score

                  The C4 Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  C4 Therapeutics

                  C4 Therapeutics Inc is a bio-pharmaceutical company. The company is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to eliminate disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.


                  Top 5 ETFs holding CCCC

                  Market Value
                  Smart Score
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Fidelity MSCI Health Care Index ETF
                  Invesco Nasdaq Biotechnology ETF
                  Up to five ETFs with an Outperform Smart Score that hold CCCC. The ETFs are listed according to market value of CCCC within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Aura Biosciences Inc
                  Biohaven Ltd.
                  Scholar Rock Holding
                  Atara Biotherapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis